跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 30,222 条关于
“Jiangsu Recbio Technology Co., Ltd.”
全部
30,222
临床试验
7,845
药物
2,273
机构
4,658
资讯
15,446
去年
Recbio Initiates Phase III Trial of REC610 Shingles Vaccine in China
去年
Eisai Advances LEQEMBI Subcutaneous and IV Maintenance Dosing Applications for Alzheimer's Disease
去年
Recbio Completes Phase III Trial Enrollment for Novel Shingles Vaccine REC610
去年
AIM Vaccine Submits 13-Valent Pneumonia Conjugate Vaccine for Approval After Positive Phase III Results
去年
Rege Nephro Secures $150 Million in Series B Funding to Advance Kidney Disease Therapies
去年
Lumosa Therapeutics' LT3001 Shows Promise in Phase II Acute Ischemic Stroke Trial
去年
Dizal Submits NDA to FDA for Sunvozertinib in EGFR Exon20ins NSCLC
去年
Newron Pharmaceuticals Expands Evenamide Reach in Asia with New Licensing Agreements
去年
AIM Vaccine's Serum-Free Rabies Vaccine Achieves Phase III Goals, Paving Way for Market Launch
去年
MS-20 Shows Remarkable Efficacy as Add-on Therapy for Ulcerative Colitis in Clinical Trial
第 1 页，共 1545 页
上一页
下一页
